Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Chebib Chekir"'
Autor:
Keiko Shimizu, Kazuhiro Tabuchi, Chebib Chekir, Aiko Sasaki, Yayoi Emi, Mikiya Nakatsuka, Yasuhiko Kamada, Yuji Hiramatsu, Miwa Matsuda, Yukako Kikuchi, Fujimi Arai, Sharula
Publikováno v:
Journal of Obstetrics and Gynaecology Research. 38:932-940
Aim: Male-to-female (MTF) transsexuals are treated with estrogen with and without progestin through a variety of routes. The aim of this study is to evaluate the arterial stiffness in MTF transsexuals undergoing hormonal treatment. Methods: We evalua
Autor:
Yasuhiko Kamada, Mikiya Nakatsuka, Aiko Sasaki, Miwa Matsuda, Sharula, Yayoi Emi, Chebib Chekir, Yuji Hiramatsu
Publikováno v:
Journal of Obstetrics and Gynaecology Research. 37:402-411
Aim: Although risk factors for cardiovascular disease, such as obesity, hyperinsulinemia, and dyslipidemia, are commonly observed in women with polycystic ovary syndrome (PCOS), impairment of vascular function is still controversial. We evaluated the
Autor:
Chebib Chekir, Yuji Hiramatsu, Aiko Sasaki, Soichi Noguchi, Yasuhiko Kamada, Mikiya Nakatsuka
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica. 84:189-195
Background. Risk factors for cardiovascular disease, including chronic anovulation, obesity, hyperandrogenism, hyperinsulinemia, and dyslipidemia, are commonly observed in women with polycystic ovary syndrome (PCOS). We evaluated uterine perfusion an
Autor:
Soichi Noguchi, Aiko Sasaki, Mikiya Nakatsuka, Yasuhiko Kamada, Chebib Chekir, Yuji Hiramatsu, Hideki Konishi
Publikováno v:
Human Reproduction. 19:2156-2162
BACKGROUND: We studied the effects of advanced glycation end products (AGEs), which are known to accumulate in patients with diabetes, autoimmune diseases, or that smoke, on human trophoblasts. METHODS: First trimester human chorionic villi of 6‐ 1
Autor:
Sharula, Chebib, Chekir, Yayoi, Emi, Fujimi, Arai, Yukako, Kikuchi, Aiko, Sasaki, Miwa, Matsuda, Keiko, Shimizu, Kazuhiro, Tabuchi, Yasuhiko, Kamada, Yuji, Hiramatsu, Mikiya, Nakatsuka
Publikováno v:
The journal of obstetrics and gynaecology research. 38(6)
Male-to-female (MTF) transsexuals are treated with estrogen with and without progestin through a variety of routes. The aim of this study is to evaluate the arterial stiffness in MTF transsexuals undergoing hormonal treatment.We evaluated the arteria
Autor:
Aiko, Sasaki, Yayoi, Emi, Miwa, Matsuda, Sharula, Yasuhiko, Kamada, Chebib, Chekir, Yuji, Hiramatsu, Mikiya, Nakatsuka
Publikováno v:
The journal of obstetrics and gynaecology research. 37(5)
Although risk factors for cardiovascular disease, such as obesity, hyperinsulinemia, and dyslipidemia, are commonly observed in women with polycystic ovary syndrome (PCOS), impairment of vascular function is still controversial. We evaluated the vasc
Autor:
Lin Hao, Aiko Sasaki, Soichi Noguchi, Chebib Chekir, Yuji Hiramatsu, Mikiya Nakatsuka, Yasuhiko Kamada, Hideki Konishi
Publikováno v:
Placenta. 27(2-3)
Advanced glycation end products (AGEs) are known to cause oxidative damage in various cells by binding with its receptor, RAGE. We measured the serum level of AGEs and examined the AGEs, RAGE, and the other biomarkers of oxidative stress in the place
Autor:
Soichi Noguchi, Yuka Sugiyama, Chebib Chekir, Yasuhiko Kamada, Yuji Hiramatsu, Mikiya Nakatsuka
Publikováno v:
Human reproduction (Oxford, England). 19(7)
Vaginal agenesis is an uncommon, but not rare, condition. Although there are many methods for creating a neovagina, the optimal treatment is unknown. An 18-year-old woman with Mayer-Rokitansky-Kuster-Hauser syndrome received vaginoplasty with a modif
Nafamostat mesilate suppresses NF-kappaB activation and NO overproduction in LPS-treated macrophages
Autor:
Takafumi Kudo, Chebib Chekir, Yasuhiko Kamada, Mikiya Nakatsuka, Soichi Noguchi, Hideki Konishi
Publikováno v:
International immunopharmacology. 3(9)
Nafamostat mesilate (NM), a clinically used serine protease inhibitor, suppressed the overproduction of nitric oxide (NO) and the expression of inducible nitric oxide synthase (iNOS) in RAW264.7 murine macrophages treated with lipopolysaccharide (LPS